Table 5. Statistics of overall survival (months) of tumor samples for ERS1 gene expression, ERS2 gene expression, CYP19A1 gene expression and aromatase protein concentration (ARO) for each combination of low and high expression groups (lower and higher than median).
ERS1 +CYP19A1 | ERS1 +ARO | ERS2+ CYP19A1 | ERS2+ARO | |||||
Class | median | N | median | N | median | N | median | N |
Low+Low | 31.0 | 29 | 26.9 | 20 | 30.5 | 26 | 28.7 | 21 |
High+Low | 33.6 | 19 | 39.4 | 23 | 31.2 | 22 | 40.5 | 25 |
Low+High | 22.2 | 19 | 29.7 | 23 | 21.4 | 22 | 22.3 | 18 |
High+High | 34.5 | 29 | 25.9 | 19 | 31.8 | 26 | 30.2 | 21 |
Log Rank | 0.0001 | 0.383 | 0.077 | 0.093 | ||||
Kruskal-Wallis | 0.011 | 0.167 | 0.126 | 0.049 |
Kaplan-Meier Log Rank (Mantel-Cox) and Kruskal-Wallis p-values are listed when comparing these different categories. N: Patient number.